Trial Profile
A Stratification trial to determine key immunological factors predicting Tofacitinib efficacy in Psoriatic Arthritis (PsA). TOFA-PREDICT TOFA-PREDICT
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2023
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Etanercept; Methotrexate; Methotrexate
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms TOFA-PREDICT
- 12 Sep 2023 Planned number of patients changed from 200 to 160.
- 17 Apr 2018 New trial record